Link to this page
Myocardial Infarction Ontology
| Preferred Name | dobutamine | |
| Synonyms |
rac-dobutamine 4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol DL-dobutamine dobutaminum racemic-dobutamine dobutamin dobutamina |
|
| Definitions |
A synthetic catecholamine with sympathomimetic activity. Dobutamine is a direct-acting inotropic agent and an adrenergic agonist that stimulates primarily the beta-1 adrenoceptor, with lesser effect on beta-2 or alpha receptors. Via beta-1 adrenoceptor of the heart, this agent induces positive inotropic effect with minimal changes in chronotropic activities or systemic vascular resistance. Dobutamine also causes vasodilation by stimulating beta-2 adrenergic receptors in blood vessels, augmented by reflex vasoconstriction resulting in increased cardiac output. [url:http://purl.obolibrary.org/obo/NCIT_C61733] |
|
| ID |
http://www.semanticweb.org/admin/ontologies/2022/7/MIO:02870 |
|
| definition |
A synthetic catecholamine with sympathomimetic activity. Dobutamine is a direct-acting inotropic agent and an adrenergic agonist that stimulates primarily the beta-1 adrenoceptor, with lesser effect on beta-2 or alpha receptors. Via beta-1 adrenoceptor of the heart, this agent induces positive inotropic effect with minimal changes in chronotropic activities or systemic vascular resistance. Dobutamine also causes vasodilation by stimulating beta-2 adrenergic receptors in blood vessels, augmented by reflex vasoconstriction resulting in increased cardiac output. [url:http://purl.obolibrary.org/obo/NCIT_C61733]
|
|
| label |
dobutamine
|
|
| MIO_ID |
MIO:02870
|
|
| prefLabel |
dobutamine
|
|
| reference |
NCIT:C61733 CHEBI:4670
|
|
| synonyms |
rac-dobutamine 4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol DL-dobutamine dobutaminum racemic-dobutamine dobutamin dobutamina
|
|
| subClassOf |
http://www.semanticweb.org/admin/ontologies/2022/7/MIO:02649 |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |